Related Experiment Video
Updated: Jul 16, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
A novel fibrinogen variant--Praha I: hypofibrinogenemia associated with gamma Gly351Ser substitution
Roman Kotlín1, Martina Chytilová, Jirí Suttnar
1Institute of Hematology and Blood Transfusion, Praha, Czech Republic. kotlinr@uhkt.cz
Objectives:
A 25-yr-old man from Prague had abnormal bleeding after several surgical operations with low fibrinogen level and hypofibrinogenemia was suspected.
Patients And Methods:
The patient, 25 yr-old male had a low fibrinogen concentration as determined by the thrombin time and immunoturbidimetrical method. His 48-yr-old mother presented with normal coagulation tests, normal fibrinogen level and reported no history of bleeding. To identify the genetic mutation responsible for this hypofibrinogen, genomic DNA extracted from the blood was analyzed. Fibrin polymerization measurement, kinetics of fibrinopeptide release, fibrinogen clottability measurement, mass spectroscopy, and scanning electron microscopy were performed.
Results:
DNA sequencing showed heterogeneous fibrinogen gammaG351S mutation in the propositus. The mutant chain was found not to be expressed to the circulation by matrix-assisted laser desorption/ionization time of flight mass spectrometry. Scanning electron micrographs of the patient's fibrin clot as well as kinetics of fibrinopeptide release and fibrin polymerization were found to be normal.
Conclusion:
A case of hypofibrinogenemia gammaG351S was found by routine coagulation testing and was genetically identified.
Insights
A genetic mutation, fibrinogen gammaG351S, caused hypofibrinogenemia in a young man, leading to abnormal bleeding. Despite the mutation, his fibrin clot formation and function appeared normal.
Area of Science:
- Hematology
- Genetics
- Biochemistry
Background:
- Hypofibrinogenemia, characterized by low fibrinogen levels, can cause bleeding disorders.
- Genetic mutations are a known cause of inherited hypofibrinogenemia.
Observation:
- A 25-year-old male presented with abnormal bleeding and low fibrinogen levels.
- Genetic analysis revealed a heterogeneous fibrinogen gammaG351S mutation in the patient.
- Mass spectrometry indicated the mutant fibrinogen chain was not expressed in circulation.
Findings:
- The identified fibrinogen gammaG351S mutation was linked to the patient's hypofibrinogenemia.
- Despite the mutation, the patient's fibrin polymerization, fibrinopeptide release, and clot structure were normal.
- The mother, with normal fibrinogen levels, did not carry the mutation.
Implications:
- This case highlights the importance of genetic identification in diagnosing hypofibrinogenemia.
- Understanding the impact of specific fibrinogen mutations is crucial for predicting bleeding risk.
- Further research may elucidate the precise mechanisms by which this mutation affects fibrinogen levels without compromising clot function.
Related Concept Videos
Clot Retraction and Fibrinolysis
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
